Dysregulated Ca Homeostasis As a Central Theme in Neurodegeneration: Lessons from Alzheimer's Disease and Wolfram Syndrome
Overview
Biophysics
Cell Biology
Molecular Biology
Authors
Affiliations
Calcium ions (Ca) operate as important messengers in the cell, indispensable for signaling the underlying numerous cellular processes in all of the cell types in the human body. In neurons, Ca signaling is crucial for regulating synaptic transmission and for the processes of learning and memory formation. Hence, the dysregulation of intracellular Ca homeostasis results in a broad range of disorders, including cancer and neurodegeneration. A major source for intracellular Ca is the endoplasmic reticulum (ER), which has close contacts with other organelles, including mitochondria. In this review, we focus on the emerging role of Ca signaling at the ER-mitochondrial interface in two different neurodegenerative diseases, namely Alzheimer's disease and Wolfram syndrome. Both of these diseases share some common hallmarks in the early stages, including alterations in the ER and mitochondrial Ca handling, mitochondrial dysfunction and increased Reactive oxygen species (ROS) production. This indicates that similar mechanisms may underly these two disease pathologies and suggests that both research topics might benefit from complementary research.
Shiga Y, Olguin A, El Hajji S, Belforte N, Quintero H, Dotigny F Cell Rep Med. 2024; 5(12):101839.
PMID: 39615485 PMC: 11722116. DOI: 10.1016/j.xcrm.2024.101839.
Beyond Wolfram Syndrome 1: The Gene's Role in Alzheimer's Disease and Sleep Disorders.
Caruso V, Rigoli L Biomolecules. 2024; 14(11).
PMID: 39595565 PMC: 11591713. DOI: 10.3390/biom14111389.
The Sigma Receptors in Alzheimer's Disease: New Potential Targets for Diagnosis and Therapy.
Wang T, Jia H Int J Mol Sci. 2023; 24(15).
PMID: 37569401 PMC: 10418732. DOI: 10.3390/ijms241512025.
Targeting Sigma Receptors for the Treatment of Neurodegenerative and Neurodevelopmental Disorders.
Malar D, Thitilertdecha P, Ruckvongacheep K, Brimson S, Tencomnao T, Brimson J CNS Drugs. 2023; 37(5):399-440.
PMID: 37166702 PMC: 10173947. DOI: 10.1007/s40263-023-01007-6.
Angeloni C, Malaguti M, Prata C, Freschi M, Barbalace M, Hrelia S Antioxidants (Basel). 2023; 12(1).
PMID: 36670956 PMC: 9854890. DOI: 10.3390/antiox12010094.